KCA has sponsored more kidney cancer research projects than any organization of its size in the world.
Chicago, IL (PRWEB) May 31, 2013
The Kidney Cancer Association (KCA) is an exhibitor at the world’s largest oncology meeting, to be held May 31 to June 4 at Chicago’s McCormick Place. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Building Bridges to Conquer Cancer.” KCA’s booth (3020) is located near the main entrance to the ASCO Exhibit Hall.
KCA’s mission is to educate and advocate on behalf of patients with kidney cancer and fund breakthrough research in the kidney cancer field. Established in 1990, KCA has collaborated with ASCO’s Conquer Cancer Foundation (CCF) since then to sponsor eight Young Investigator Awards (YIA), the Foundation’s research grants for early-career physician scientists.
“We partnered with CCF to award an annual YIA because of the expertise resident in the organization, because of the difference in scale—we knew that they would receive more and better-quality proposals—and because of the efficiency of the process, which relieves our small organization of the financial and logistic burden of reviewing proposals,” said Bill Bro, KCA Chief Executive Officer. “We’re very pleased with our collaboration. It’s an extremely effective synergy.”
Each year, more than 60,000 people in the United States are diagnosed with kidney cancer, and more than 13,000 people lose their battle with this disease. Kidney cancer is the sixth most common cancer for men and the eighth most common cancer for women.
KCA has sponsored more kidney cancer research projects than any organization of its size in the world. In its most recent fiscal year, KCA invested more than $650,000 in research-related program activities. It also sponsors the genitourinary cancers sessions at the ASCO Annual Meeting.